701 Pennsylvania Ave. N.W.
Suite 700
Washington, DC 20004
(202) 737-5980
dmaa@dmaa.org
www.dmaa.org

Sunday, Sept. 7, 1:30 - 2 p.m.

For almost two decades, clinicians have attempted to monitor patients with chronic conditions, such as congestive heart failure, in their home environment. Many landmark studies have attempted to quantify the benefit of critical outcomes, such as mortality, hospitalization and cost effectiveness. Although each trial was scientifically based, results of their primary outcomes varied widely from study to study. Hear about a meta-analysis of key trials in remote patient management with interim results from trials currently in progress. Variability in results from these trials can be attributed to differences in home monitoring technologies, variation in disease management programs and lack of adequate power in study sample sizes, duration and other metrics. Understand value models and return on investment calculations.

Mark A. Johnson, BSEE, MBA, is clinical trials manager for Intel Corporation's Digital Health division. He is a 20-year veteran of the medical device industry in engineering, business development, clinical studies and marketing. Previously, he was a business development manager for the first implantable RPM technology introduced by Biotronik.

DMAA conducted an in-depth, comprehensive study on the state of the disease management and wellness industry. This study was specifically designed to deliver new quantitative insights regarding size of the industry, performance of disease management and wellness programs, future growth plans and industry trends. This session will present the final report, which identifies the most prevalent payer-sponsored disease management programs, program measures of success and the disease management programs that most effectively reduce care costs.

Elaine Mischler, MD, is the principal of Mischler Consultants LLC and works primarily with self-funded employers on health care strategy and innovation. She is the co-chair of DMAA's Market Analysis Committee. Dr. Mischler is a physician executive with more than 30 year of experience as a clinician, teacher, speaker and researcher in academic, community health organizations, health benefits administration and managed health care.

Disease management organizations support individuals with a wide range of chronic conditions along the care continuum, including those facing end-of-life care decisions. Yet many organizations only have a passing understanding of hospice, palliative care and advance care planning. A 2007 study by researchers at Duke University found that hospice reduced Medicare costs by an average of $2,309 per hospice patient and is more cost effective for non-cancer patients for more than five months of care. Yet the average length of stay for hospice patients is only 59 days with a median length of stay of only 20.6 days. In this session: learn how palliative care and hospice can benefit disease management clients; understand common triggers for referral to palliative care and hospice; and identify ways to partner with end-of-life care providers to increase quality of life and optimize resources.

Christin Regas, MSW, is director of consumer programs and services director at the National Hospice and Palliative Care Organization (NHPCO). She joined the staff at NHPCO in 2003, after working as a hospice social worker. For more than 10 years, she has specialized in end-of-life care, focusing on end-of-life care planning, access to care and consumer advocacy.

Hear results from the first randomized population trial comparing the reach of three relatively low-cost additive recruitment strategies and the impact of three of the most popular interventions in worksite health management: health risk assessment and intervention (HRI) only; online HRI plus Transtheoretical Model tailored communications; and online HRI plus motivational interviewing-based health coaching. Of the nearly 12,000 employees from Oregon Health Science University available at the start of the study, 5,994 received one of the three recruitment interventions. Gain a better understanding of impact versus efficacy of worksite interventions plus be able to identify the attributes of two successful health promotion interventions that significantly lower risk factors and increase productivity at the worksite.

Susan W. Butterworth, PhD, is the director and founder of OHSU Health Management Services. Her doctorate from Virginia Commonwealth University is in adult education and training, with a health promotion cognate. She holds the position of associate professor at Oregon Health and Science University and is the president of Q-Consult.

This presentation will highlight an advanced medical home demonstration project between an integrated health system and health insurance company, a novel approach that enhances care coordination for primary care patients and intensifies chronic condition care to improve health and financial outcomes. The presentation will define the advanced medical home, describe the model of care delivery and review outcomes. Building on the success of an earlier diabetes program and restructuring nurse roles to keep increased nurse salary costs to a minimum, the demonstration project focuses on diabetes, coronary vascular disease and hypertension and integrates preventive care services. The population, adults seen at one of four project clinics, is estimated at 3,164 patients.

Wanda Hanson, RN, MSN, is chronic disease coordinator at MeritCare Health System. She received her bachelor's in nursing from the University of North Dakota and her master's in gerontological nursing from the University of California, San Francisco. Ms. Hanson is experienced in hospice and home care.